| Home > Publications Database > ALS is imprinted in the chromatin accessibility of blood cells. > print |
| 001 | 257780 | ||
| 005 | 20240227115129.0 | ||
| 024 | 7 | _ | |a 10.1007/s00018-023-04769-w |2 doi |
| 024 | 7 | _ | |a pmid:37095391 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC10126052 |2 pmc |
| 024 | 7 | _ | |a 1420-682X |2 ISSN |
| 024 | 7 | _ | |a 0014-4754 |2 ISSN |
| 024 | 7 | _ | |a 1420-9071 |2 ISSN |
| 024 | 7 | _ | |a altmetric:146570864 |2 altmetric |
| 037 | _ | _ | |a DZNE-2023-00495 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kühlwein, Julia |0 P:(DE-2719)9001523 |b 0 |u dzne |
| 245 | _ | _ | |a ALS is imprinted in the chromatin accessibility of blood cells. |
| 260 | _ | _ | |a Cham (ZG) |c 2023 |b Springer International Publishing AG |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1708963820_5082 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Amyotrophic Lateral Sclerosis (ALS) is a complex and incurable neurodegenerative disorder in which genetic and epigenetic factors contribute to the pathogenesis of all forms of ALS. The interplay of genetic predisposition and environmental footprints generates epigenetic signatures in the cells of affected tissues, which then alter transcriptional programs. Epigenetic modifications that arise from genetic predisposition and systemic environmental footprints should in theory be detectable not only in affected CNS tissue but also in the periphery. Here, we identify an ALS-associated epigenetic signature ('epiChromALS') by chromatin accessibility analysis of blood cells of ALS patients. In contrast to the blood transcriptome signature, epiChromALS includes also genes that are not expressed in blood cells; it is enriched in CNS neuronal pathways and it is present in the ALS motor cortex. By combining simultaneous ATAC-seq and RNA-seq with single-cell sequencing in PBMCs and motor cortex from ALS patients, we demonstrate that epigenetic changes associated with the neurodegenerative disease can be found in the periphery, thus strongly suggesting a mechanistic link between the epigenetic regulation and disease pathogenesis. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Chromatin remodeling |2 Other |
| 650 | _ | 7 | |a Epigenome |2 Other |
| 650 | _ | 7 | |a Integrated analysis |2 Other |
| 650 | _ | 7 | |a Motor neuron disease |2 Other |
| 650 | _ | 7 | |a Regulatory elements |2 Other |
| 650 | _ | 7 | |a Single-nuclei sequencing |2 Other |
| 650 | _ | 7 | |a Chromatin |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: metabolism |2 MeSH |
| 650 | _ | 2 | |a Epigenesis, Genetic |2 MeSH |
| 650 | _ | 2 | |a Chromatin |2 MeSH |
| 650 | _ | 2 | |a Genetic Predisposition to Disease |2 MeSH |
| 650 | _ | 2 | |a Neurodegenerative Diseases: genetics |2 MeSH |
| 650 | _ | 2 | |a Blood Cells: metabolism |2 MeSH |
| 650 | _ | 2 | |a Blood Cells: pathology |2 MeSH |
| 700 | 1 | _ | |a Ruf, Wolfgang |0 P:(DE-2719)9001522 |b 1 |u dzne |
| 700 | 1 | _ | |a Kandler, Katharina |b 2 |
| 700 | 1 | _ | |a Witzel, Simon |0 P:(DE-2719)9001976 |b 3 |u dzne |
| 700 | 1 | _ | |a Lang, Christina |0 P:(DE-2719)9002237 |b 4 |u dzne |
| 700 | 1 | _ | |a Mulaw, Medhanie A |b 5 |
| 700 | 1 | _ | |a Ekici, Arif B |b 6 |
| 700 | 1 | _ | |a Weishaupt, Jochen H |0 P:(DE-2719)9000455 |b 7 |u dzne |
| 700 | 1 | _ | |a Ludolph, Albert C |0 P:(DE-2719)2812633 |b 8 |u dzne |
| 700 | 1 | _ | |a Grozdanov, Veselin |0 P:(DE-2719)9001519 |b 9 |u dzne |
| 700 | 1 | _ | |a Danzer, Karin M |0 P:(DE-2719)9001513 |b 10 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1007/s00018-023-04769-w |g Vol. 80, no. 5, p. 131 |0 PERI:(DE-600)1458497-9 |n 5 |p 131 |t Cellular and molecular life sciences |v 80 |y 2023 |x 1420-682X |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257780/files/DZNE-2023-00495%20SUP1.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257780/files/DZNE-2023-00495%20SUP2.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257780/files/DZNE-2023-00495%20SUP1.pdf?subformat=pdfa |x pdfa |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257780/files/DZNE-2023-00495.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/257780/files/DZNE-2023-00495.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:257780 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9001523 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-2719)9001522 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 3 |6 P:(DE-2719)9001976 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 4 |6 P:(DE-2719)9002237 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 7 |6 P:(DE-2719)9000455 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)2812633 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 9 |6 P:(DE-2719)9001519 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)9001513 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2022-11-11 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2022-11-11 |w ger |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 920 | 1 | _ | |0 I:(DE-2719)5000072 |k AG Danzer |l Mechanisms of Propagation |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)5000077 |k Clinical Study Center Ulm |l Clinical Study Center Ulm |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)5000072 |
| 980 | _ | _ | |a I:(DE-2719)5000077 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|